MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 158 filers reported holding MERSANA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,263 | +403.8% | 2,021,467 | +1205.0% | 0.01% | +250.0% |
| Q2 2023 | $509,618 | -44.5% | 154,899 | -30.7% | 0.00% | -85.7% |
| Q1 2023 | $918,125 | +1853.5% | 223,388 | +2076.4% | 0.01% | +1300.0% |
| Q2 2022 | $47,000 | -97.0% | 10,264 | -97.4% | 0.00% | -97.6% |
| Q1 2022 | $1,573,000 | -35.9% | 394,250 | -0.1% | 0.04% | -44.7% |
| Q4 2021 | $2,455,000 | +118.2% | 394,760 | +230.9% | 0.08% | +137.5% |
| Q3 2021 | $1,125,000 | +113.5% | 119,302 | +207.4% | 0.03% | +77.8% |
| Q2 2021 | $527,000 | +2191.3% | 38,815 | +172.3% | 0.02% | +1700.0% |
| Q3 2019 | $23,000 | -59.6% | 14,252 | +1.8% | 0.00% | -83.3% |
| Q2 2019 | $57,000 | – | 14,003 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |